The ANMV also obtained the following recognitions:
- as a member of the European network of Official Medicines Control Laboratories (OMCLs), the laboratory of the market surveillance unit has participated since 2007 in the Mutual Joint Audit, a programme organised by the European Directorate for the Quality of Medicines and HealthCare (EDQM). This recognition was renewed in January 2020;
- since 2009, the French agency for veterinary medicinal products has been recognized by the Pharmaceutical Inspection Cooperation Scheme (international);
- in 2012, an assessment of the system for inspecting testing facilities conducted by the OECD (Organisation for Economic Co-operation and Development) enabled the ANMV to obtain the renewal of its compliance recognition as the competent authority for the inspection of good laboratory practices in the field of veterinary medicines;
- in 2018, an assessment was conducted with regard to the work methods and quality management system for inspections. The Joint audit Program recognition was renewed.
The ANMV also takes part in the European benchmarking exercise (BEMA) in which all the competent European authorities for human and veterinary medicinal products participate. This exercise is an assessment of the agencies by their peers (auditors from other European agencies), based on a questionnaire which applies the requirements of the ISO 9001 standard. This exercise is a veritable tool for improving the quality management approach supported by ANMV management.
A quality policy declaration (PDF) by the Agency’s director (pdf in French) is testimony to the ANMV’s commitment to quality management, establishing a process-based approach and, more recently, a risk-based approach.
The ANMV has a complaint management procedure which is available upon request from the quality manager.